# Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers

> **NCT01490008** · PHASE1 · COMPLETED · sponsor: **MediGene** · enrollment: 30 (actual)

## Conditions studied

- Anogenital Warts

## Interventions

- **DRUG:** Veregen
- **OTHER:** Green Tea

## Key facts

- **NCT ID:** NCT01490008
- **Lead sponsor:** MediGene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01490008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01490008, "Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01490008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*